Improvements in depression scores for patients with TRD did not significantly differ among those assigned an adjuvant online lifestyle modification program, mindfulness-based cognitive therapy, or a placebo control intervention.
Improvements in depression scores for patients with TRD did not significantly differ among those assigned an adjuvant online lifestyle modification program, mindfulness-based cognitive therapy, or a placebo control intervention.
Data from more than 50 real-world studies suggest a monoclonal antibody is effective among patients with relapsing-remitting and primary progressive multiple sclerosis.
Data from more than 50 real-world studies suggest a monoclonal antibody is effective among patients with relapsing-remitting and primary progressive multiple sclerosis.
People with multiple sclerosis (MS) averaged 21 fewer minutes of moderate-to-vigorous physical activity and 25 fewer minutes of light physical activity per day compared with healthy controls.
People with multiple sclerosis (MS) averaged 21 fewer minutes of moderate-to-vigorous physical activity and 25 fewer minutes of light physical activity per day compared with healthy controls.
A real-world study tested the efficacy and safety of PD-1 inhibitors for patients with non-small cell lung cancer after treatment with tyrosine kinase inhibitors failed.
A real-world study tested the efficacy and safety of PD-1 inhibitors for patients with non-small cell lung cancer after treatment with tyrosine kinase inhibitors failed.
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment.
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment.